THE LEADING PHARMACEUTICAL COMPANY IN BOSNIA AND HERZEGOVINA
We are committed to meeting the expectations of our customers, shareholders and employees.
Investors
Bosnalijek d.d. is in the official quotation of the Sarajevo Stock Exchange (www.sase.ba) under ticker symbol BSNLR. We regularly rank among the top 5 most liquid stocks on the SASE and are classified in the SASX - 10 index. In this section of You can find more information on our business operations our web page.

BSNLR (BAM) KM
Average price: BAM
Change:
Best bid price: BAM
Best ask price: BAM
Volume:
Value: BAM
Number of transactions:
News
PRESS CENTAR / NEWS
Bosnalijek achieves Record Turnover of 107 million BAM in Foreign Markets
Bosnalijek recorded great business results in 2017, further underlining its reputation as the leading pharmaceutical company in Bosnia and Herzegovina (BiH). This is confirmed by achieved sales revenue to the amount of 153 million BAM, which represents an increase of 17 million BAM or 13 per cent in comparison to 2016. Profit before tax was 13 million BAM, an increase of 12 per cent compared to profit generated in 2016.
In detail
PRESS CENTAR / NEWS
Continuous Growth: Bosnalijek Revenue increases by 35 per cent in 2017
During the first ten months of 2017, Bosnalijek revenue increased by 35 per cent compared to the same period in the previous year.
In detail
ANNUAL GENERAL ASSEMBLY/NOTICE
Annual General Assembly of Bosnalijek d.d.
Annual General Assembly of Bosnalijek d.d. company is convoked on 23/05/2017 with opening at 10:00 h. The Assembly session will be held in premises of Bosnalijek d.d. headquarters with address at 53 Jukićeva St., 71000 Sarajevo.
MORE
august 15. 2018 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%